Anthropic
Databricks
Anduril
OpenAI
Stripe
Saronic

Private Markets
Pulse #21

October 22–29

Vladislav SolovevPartner & Head of Research

The index fell 0.9% while the Nasdaq-100 rose 2.4%. The largest supply volumes were in Anthropic, OpenAI and Anduril. Wealthsimple is raising up to C$425M at a $9.8B valuation, Bedrock Robotics raised $600M at a $4.1B valuation, and Intel is buying Classiq for $2.2B.

Market Pulse

Axevil Pre-IPO Index

7,676Axevil Pre-IPO Index
−0.9%Pre-IPO · Weekly
30,539Nasdaq-100
+2.4%Nasdaq · Weekly

Axevil Pre-IPO Index vs Nasdaq-100

+46% vs +21%

Year-to-Date Performance, %

Axevil Pre-IPO Index vs Nasdaq-100, % year to date
WeekPre-IPO Index, %Nasdaq-100, %
Jan 100
Jan 85.91.1
Jan 1511.90.9
Jan 22100.4
Jan 2912.83.1
Feb 59-1.3
Feb 1210.9-0.6
Feb 198-1.3
Feb 2611.90.3
Mar 510-0.7
Mar 1210.9-0.9
Mar 197-3.2
Mar 2610-4.2
Apr 213.9-4.4
Apr 920-0.6
Apr 1627.73.9
Apr 2325.17.1
Apr 3030.97.5
May 73614
May 1442.715.6
May 213916
May 2833.218.6
Jun 43421
Jun 1135.914
Jun 183516.2
Jun 2531.216
Jul 235.818
Jul 938.716
Jul 1639.816.5
Jul 2340.915.4
Jul 3043.78.2
Aug 64816.8
Aug 1346.717.4
Aug 2044.116.6
Aug 2743.715.8
Sep 340.415.7
Sep 1039.516.4
Sep 174214.7
Sep 2444.320
Oct 143.220.4
Oct 84523.2
Oct 1546.521.2
Oct 2247.818.2
Oct 294621

The private market took a pause: the index fell 0.9% to 7,676 points. The Nasdaq-100 rose 2.4% as Anthropic filed its prospectus. Year to date the index is up 46% versus 21% for the Nasdaq-100.

Private Market Map by Sector

Weekly order volume

Private Market Map by Sector
NameValueNote
Models and labs70.4%Anthropic, OpenAI, Mistral AI, Reflection AI
Defense, robotics and neurotech13.6%Anduril, Saronic, Neuralink, Applied Intuition
AI infrastructure6.3%Databricks, Cognition, Fireworks AI, Crusoe
Fintech and crypto5.6%Stripe, Revolut, Monzo
Applied AI and consumer4.2%ByteDance, ElevenLabs, Higgsfield

Models and labs account for 70.4% of the aggregate order book. Most of the volume is in Anthropic, OpenAI and Mistral AI. Defense, robotics and neurotech account for 13.6%: Anduril, Saronic and Neuralink. AI infrastructure takes 6.3%, led by Databricks, Cognition and Fireworks AI; fintech and crypto take 5.6%: Stripe, Revolut and Monzo. Applied AI and consumer account for 4.2%: ByteDance, ElevenLabs and Higgsfield.

Data: Axevil.

Secondary Market

Trading Activity

The aggregate order book for the week came to $29.2B: demand of $8.4B (29%) and supply of $20.8B.

$29.2BWeekly order book
$8.4BDemand · 29%
$20.8BSupply

Demand: Buy Order Volume

Demand: Buy Order Volume
NameValueNote
Anthropic$4.4B
Databricks$720M
Stripe$514M
Anduril$411M
OpenAI$235M
ElevenLabs$200M
Revolut$182M
Neuralink$180M
Ramp$150M
Saronic$136M

Supply: Sell Order Volume

Supply: Sell Order Volume
NameValueNote
Anthropic$10.3B
OpenAI$5B
Anduril$1.9B
Saronic$310M
ByteDance$280M
Mistral AI$240M
Applied Intuition$170M
Higgsfield$156M
Monzo$150M
Stripe$115M

The largest supply volumes were in Anthropic ($10.3B), OpenAI ($5B) and Anduril ($1.9B). Demand was led by Anthropic ($4.4B), Databricks ($720M), Stripe ($514M) and Anduril ($411M).

Takeaway

Ahead of its IPO, Anthropic accounts for most of the volume on both sides; on the supply side, so does OpenAI.

$4.4Bof $8.4B in demand
52% of demand
$10.3Bof $20.8B in supply
50% of supply

Data: Axevil.

News

Key Private Company News

  1. Anthropic filed its IPO prospectus.

    The company published its S-1 for a Nasdaq listing under the ticker ANT. Revenue for the first half of 2026 came to $16.3B versus $1.2B a year earlier, and in Q2 Anthropic posted an adjusted operating profit for the first time. The expected valuation is $1.5–2T, with the offering planned before November 26.

  2. Moonshot AI released Kimi K3.1 Pro.

    A flagship 2.8-trillion-parameter language model with a 1M-token context window. According to the company, it scores 65.7% on Terminal-Bench 4.0 versus 66.4% for Claude Opus 5.5, at an API price of $2 per million input tokens. Open weights are promised by November 4.

  3. Anthropic showed its first results in drug development.

    The company works with 6 drug developers, including Bristol Myers Squibb and Generate Biomedicines, and acquired Mithril Medicine. Claude prepared a regulatory filing in 4 hours instead of 3 months and designed a CAR-T therapy variant 70% more compact than the standard one.

  4. Higgsfield is preparing a round at a $12–14B valuation.

    Nvidia and TCV joined the Series B of the video and image generation platform. ARR has passed $1.4B, with more than 40M users. According to insiders, the new round is expected in late November; in August the company was valued at $5.4B.

  5. Jio Platforms completed the largest IPO in India’s history.

    The company raised $3.2B and was 22 times oversubscribed. Its shares rose 26.7% on the first day of trading, taking the valuation to ₹13.05T ($137B) and making Jio India’s second-largest company by market capitalization.

  6. Physical Intelligence

    A developer of general-purpose AI models for robots, is in talks to raise at least $1B at a $20B valuation, according to Bloomberg. In May the company closed a round at $11B.

  7. OpenAI released GPT-6.1 Terra

    A model for AI agents that runs faster than its predecessor at half the price.

  8. S&P Dow Jones Indices chose Kalshi as its primary venue for event contracts

    On its indices, including the S&P 500, and will build indices on Kalshi data.

  9. Revolut is creating Revolut Ventures

    A platform for clients to invest in private tech companies, together with Carne Group. The in-app launch is planned for 2027.

New Rounds of the Week

14 rounds of $100M or more closed during the week, totaling $5.5B. The largest was Re:Build Manufacturing at $2.1B, valuation undisclosed. The highest valuation was Wealthsimple at $9.8B.

Top 10 by Valuation

Series DFuriosaAI

FuriosaAI

$620Mvaluation $2.9B
Series CBedrock Robotics

Bedrock Robotics

$600Mvaluation $4.1B
Series CUpwind

Upwind

$400Mvaluation $3.8B
Late StageWealthsimple

Wealthsimple

C$425Mvaluation $9.8B
Series EPathos AI

Pathos AI

$237Mvaluation $3B
Series AWarp Sciences

Warp Sciences

$215Mvaluation $865M
Out of StealthWarhound

Warhound

$200Mvaluation $1.2B
Series DTractian

Tractian

$130Mvaluation $1.4B
Late StageHex

Hex

$100Mvaluation $1.2B
Series AGeneral Compute

General Compute

$100Mvaluation $800M

Exits and Liquidity

The Week’s Largest Deals

IPO · NSE/BSEJio Platforms

Jio Platforms

$3.2B+26.7% on day one, valuation $137B
acquired by IntelClassiq

Classiq

$2.2BSoftware for quantum computers, three times its 2025 valuation
acquired by Guidewirehyperexponential

hyperexponential

$1.7BAI underwriting, up to $2B with earn-out
acquired by FerringGameto

Gameto

up to $1.38BIVF without hormonal stimulation
acquired by ItaúNeoSpace

NeoSpace

$589MAI models for credit scoring and anti-fraud
IPO · NasdaqLycia Therapeutics

Lycia Therapeutics

$318MProtein degradation, +67% on day one

Sources are linked in company names.

This communication is sent by Axevil Capital LLC and is intended exclusively for accredited investors. The information contained herein (including attachments) is provided solely for informational purposes and does not constitute an investment recommendation, an offer, a public offer, an invitation to make an offer or any other inducement to enter into transactions in securities or other financial instruments.

Valuations, opinions, and forecasts are based on sources believed to be reliable as of the date of publication, but their accuracy, completeness, or timeliness is not guaranteed, and they are subject to change without prior notice. Axevil Capital LLC is not responsible for any losses incurred as a result of using the information provided.

Investments in non-public companies involve a high degree of risk and limited liquidity and may result in a total loss of invested capital.

Get started

I invest directly

Create your account in a minute. Then get the app and log in with the same email.

Create account

I’m an advisor or partner

Axevil Pro is by invitation. Request access and book a demo with our team.

Already have an account? Log in

San Francisco548 Market St, San Francisco, California, 94104, United States
DubaiThe One Tower, 23rd Floor, Office 13, Dubai, United Arab Emirates
AstanaOffice 338, 55/23 Mangilik El Avenue, Astana, Republic of Kazakhstan

Axevil Capital, LLC is a company (Delaware, #6832739) with legal address: 548 Market St, San Francisco, California, 94104, United States.

Axevil Capital, LLC has Exempt Reporting Adviser (ERA) status (SEC #802−126907).

The information presented on the website is for informational purposes only and:
— does not constitute an offer to buy or sell securities or other financial instruments;
— does not constitute an invitation to trade or provision of investment services;
— does not constitute individual investment advice.

The Company works exclusively with qualified investors who possess the necessary knowledge, experience, and financial capacity to assess risks and invest in high-risk instruments. This asset class involves elevated risks, volatility, and illiquidity. Investors must be prepared to accept the possibility of total loss of invested capital as well as lack of liquidity.

NOTIFICATION OF INVESTMENT RISKS AND STATUS OF THE COMPANY'S ACTIVITIES

FOR ALL INVESTORS GENERALLY:
The Company's activities focus on attracting investments in mature venture projects at the stage of sustainable business development, close to IPO exit.
The Company does not guarantee profit generation. Investments involve risks, including the possibility of returns below expectations, which cannot be guaranteed.

NOTICE TO INVESTORS IN THE UNITED STATES:
— Investment interest offerings are conducted as private placements and are not subject to registration under US securities laws.
— Available only to accredited investors.
— Such securities may have transfer and resale restrictions.
— Investments carry a high level of financial risk.
— Independent legal, tax, and financial consultation is strongly recommended before making investment decisions.

NOTICE TO RESIDENTS OF THE UNITED ARAB EMIRATES (UAE):
— Investment interest offerings are not public in the UAE.
— Directed only to qualified institutional investors.
— Interests are not registered or approved by the UAE Central Bank, SCA, or other regulators.

NOTICE TO RESIDENTS OF ITALY:
— Interest offerings are not authorized by Italian regulators under Decreto Legislativo No. 58/1998.
— Interests may not be offered, distributed, or sold to the general public.

NOTICE TO RESIDENTS OF THE UNITED KINGDOM:
— SPVs constitute unregulated collective investment schemes under FSMA 2000.
— Promotion is restricted and permitted only to "relevant persons" within the meaning of Financial Promotion Order 2005 (Articles 19(5), 49(2)(a)-(d)).
— Most standard protections of the UK regulatory system do not apply.
— Compensation under the UK Financial Services Compensation Scheme is not provided.

NOTICE TO RESIDENTS OF SWEDEN:
— The partnership is not an investment fund under the Swedish Investment Funds Act (2004:46).
— The offering is not subject to registration under the Swedish Financial Instruments Trading Act (1991:980).
— Interests are not approved and will not be approved by the Swedish Financial Supervisory Authority.

NOTICE TO RESIDENTS OF SWITZERLAND:
— SPVs are not approved by FINMA as foreign collective investment schemes under Article 120 CISA. Interests may not be publicly offered or distributed in Switzerland.
— SPVs are not regulated by Swiss authorities.
— Interests are available only to "qualified investors" under CISA or a limited circle of persons without public offering.
— By continuing, you confirm that:
1. You qualify as an accredited/qualified investor under the laws of your jurisdiction (e.g., in the U.S. an annual income exceeding $200,000 individually or $300,000 jointly, or net worth above $1 million, excluding primary residence).
2. You are legally permitted to access this information in your jurisdiction.
3. You understand that private investments involve a high degree of risk, including the risk of total loss of capital.

Axevil Capital 2021−2026 — All Rights Reserved